Proteome of the human heart mapped for the first time

Researchers have now determined which and how many individual proteins are present in each type of cell that occurs in the heart. In doing so, they compiled the first atlas of the healthy human heart, known as the cardiac proteome. The atlas will make it easier to identify differences between healthy and diseased hearts in future.

Proteins are the molecular machines of cells, in which they perform a range of functions. They are produced by the cells based on blueprints stored in their DNA. Changes occurring at the DNA or protein level can lead to disorders. For such changes to be recognised as underlying causes of heart disease, it is important to know precisely which proteins are present in the healthy heart and in what quantities.

Protein map of the heart

The first such protein atlas of the heart was developed by the research team at Max Planck Institute of Biochemistry (MPIB) and the German Heart Centre at the Technical University of Munich (TUM). The scientists determined the protein profile of cells in all the regions of the heart, such as heart valves, cardiac chambers and major blood vessels. In addition, they investigated the protein composition of three different cell types of the heart: cardiac fibroblasts, smooth muscle cells and endothelial cells. In this way, the researchers were able to map the distribution of proteins in the various regions of the heart. Using mass spectrometry, they identified nearly 11,000 different proteins throughout the heart.

Previous studies had focused for the most part only on individual cell types, or they used tissue from diseased hearts. “This approach has two problems,” says Sophia Doll of the MPIB and lead author of the study. “First, the results did not give a full picture of the heart across all its regions and tissues; and second, comparative data on healthy hearts were often missing. Our study has eliminated both problems. Now the data can be used as a reference for future studies.”

“Looking at the protein atlas of the human heart, you can see that all healthy hearts work in a very similar manner. We measured similar protein compositions in all the regions with few differences between them,” says Ms Doll. We were also surprised to find that the right and left halves of the heart are similar, despite having quite different functions: the right half pumps oxygen-poor blood to the lungs, while the left half pumps oxygen-rich blood from the lungs to the body.

Identifying differences

In the next step, the team wanted to test whether the data from healthy hearts could serve as a control for detecting changes in diseased hearts. They compared their values with the cardiac proteomes of patients with atrial fibrillation, a very common rhythm disorder of the heart. The results indeed provided initial clues as to the cause of the disease. The tissue of the diseased hearts was most different in proteins responsible for supplying energy to the cells.

The comparison provided yet another interesting finding: Although the proteins involved in energy metabolism were changed in all the patients, those changes differed between individuals. “These findings show us how important personalised medicine is. Although all the patients had very similar symptoms, we see from the data that a different molecular dysfunction was responsible in each case. We need to learn to recognise and treat such individual differences – especially in cardiac medicine,” says Adjunct Teaching Professor  Markus Krane, Deputy Director of the Department of Cardiovascular Surgery of the German Heart Centre Munich at TUM.

Together with his colleagues at the Department of Cardiovascular Surgery Director: Professor Rüdiger Lange, Prof Krane collected more than 150 tissue samples from over 60 cardiac operations and forensic samples. Using elaborate cell culture methods, they were able to extract the various cell types from them.

This large amount of cardiac material was a crucial factor for studying the individual heart regions so precisely. Professor Matthias Mann, head of the Proteomics and Signal Transduction Group at the MPIB, and his team carried out extensive mass spectrometric measurements. Thanks to advances in mass spectrometry and sample processing, the researchers are lighting the way towards personalised medicine.

The team at MPIB attaches great importance to precise, repeatable and fast analytical methods. They have improved the measuring technique to the extent that an entire heart region can now be determined in less than two days – twice as fast as before. This is crucial, especially for potential use on patients.

The study has been published in Nature Communications.